Share on

Asia-Pacific eClinical Solutions Market Research Report – Segmented By Product, Delivery Mode, Development Phase, End-User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Analysis on Size, Share, Trends & Growth Forecast (2023 to 2028)

Published: March, 2023
ID: 10417
Pages: 110
Formats: report pdf report excel report power bi report ppt

APAC eClinical Solutions Market Size (2023 to 2028)

The size of the Asia-Pacific eClinical solutions market is predicted to grow from USD 1.99 billion in 2023 to USD 4.05 by 2028, growing at a CAGR of 15.25% from 2023 to 2028.

The growing number of clinical trials in the pharmaceutical and biotechnology industries is majorly driving the eClinical solutions market in the Asia-Pacific. eClinical Solutions provides data by eliminating redundancies and providing real-time data for practical analysis in the pharmaceutical sector. Due to increasing drug development in the pharmaceutical industries, eClinical solutions are required to support and manage the production and demand of drugs without incurring any losses for the company. In addition, this solution provides data related to drug usage from all the healthcare industries for pharmacies to understand better which drugs and vaccines to be manufactured by clinical trials.

The growing usage of software solutions in clinical trials further boosts the Asia-Pacific region's market growth. The software used in these clinical trials is how the clinical trials are being performed, and all outcomes are recorded. The information stored in this software solution helps researchers understand the problematic stages of drug development to prepare the drug for the qualitative and quantitative tests the government puts them through. In addition, this software is also used to help with planning and managing data throughout the development of a particular product.

The rising number of research programs in Asia is also favoring the growth rate of the eClinical solutions market in the Asia-Pacific region. Owing to the increase in the incidence of chronic diseases, most researchers are focusing on developing various types of vaccines and drugs for improving patient health. Research is done in multiple ways by collecting data from the eClinical solutions, which provides complete data from different electronic health records and some other health-related records and helps the researcher to find the best drug by clinical trials to cure the diseases.

However, data collection has become complex in recent years due to the large amount of collected data. The associated data security and privacy issues are showing a negative impact on the growth of the eClinical solutions market in this region. Furthermore, high costs associated with the maintenance of clinical-related software also restrain the market growth. Furthermore, a lack of awareness regarding eClinical solutions among researchers is impeding market growth.

This research report on the Asia Pacific eClinical solutions market has been segmented & sub-segmented into the following categories:

By Product:

  • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
  • Clinical Trial Management Systems (CTMS)
  • Clinical Analytics Platform
  • Randomization and Trial Supply Management (RTMS)
  • Clinical Data Integration Platform
  • Electronic Clinical Outcome Assessment (eCOA)
  • Safety Solutions
  • Electronic Trial Master Files (eTMF)
  • Regulatory Information Management Solutions (RIMS)
  • Others

By Delivery Mode:

  • Web-hosted (On-demand)
  • Licensed Enterprise (On-premise)
  • Cloud-based

By Development Phase:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By End-User:

  • Hospitals
  • CROs
  • Academic institutes
  • Pharma & Biotech Organizations
  • Medical Device Manufacturers

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The eClinical solutions market in the Asia-Pacific market is believed to showcase a fast pace during the forecast period. Increasing demand for e-clinical solutions in the Asia-Pacific region and increased government spending on clinical trials owing to the spread of infectious diseases worldwide are promoting the eClinical solutions market in this region. In addition, government investments in the Asia Pacific region have doubled in recent years due to the outbreak of COVID-19. eClinical trials help produce different types of vaccines used for fast cures. eClinical solution provides the government with all the details about drug development, leading them to invest more in priority-based clinical trials.

Japan is one of the potential markets in the APAC region, followed by China. The eClinical solutions market in Japan is driven by factors such as a surge in research and expenditure activities by pharmaceutical and biotechnology companies for drug enhancements. Japan has also introduced eClinical solutions in the past few years and increased its usage. In addition, most clinical management companies have partnered to improve clinical trials in the region.

The Chinese eClinical solutions market is expected to perform well during the forecast period. The Chinese market is strongly supported by government funds and investment advancements to assist clinical research to be carried on. China is most advanced in the pharmaceutical and biotechnology industry because there are many key players in the region. Researchers in the region always try to produce the best drug products due to the presence of many people. Therefore, they have several clinical trials conducted on drug development for consumer safety. eClinical solution helps reduce drug development costs because of the utilization of the available information in the systems enabling manufacturers to avoid making errors. In China, nearly one thousand clinical trials were conducted in 2019. This clinical trial number has increased in recent years due to the increasing number of diseases and the increasing use of eClinical solutions in this region.

India is believed to be the quickest-growing country in the region. Factors like a massive increase in the elder people population and an expected increase in chronic diseases like cancer, CVD conditions, and infectious diseases are surging the APAC market growth.

KEY MARKET PLAYERS:

A few of the notable companies operating in the Asia Pacific eClinical Solutions Market profiled in this report are Oracle Corporation, Medidata Solutions, Inc., Parexel International Corporation, Bioclinica, Inc., Datatrak International, Inc., CRF Health, ERT Clinical, Merge Healthcare Incorporated, Omnicomm Systems, Inc., Maxisit Inc., Bio-Optronics, Inc., and Eclinical Solutions, LLC.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample